AIG
HAE icon

American International Group’s Haemonetics HAE Stock Holding History

American International Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-91,532
Closed -$7.81M – 1149
2024
Q1 		$7.81M Sell
91,532
-1,528
-2% -$120K 0.03% 542
2023
Q4 		$7.96M Sell
93,060
-2,999
-3% -$259K 0.03% 514
2023
Q3 		$8.6M Sell
96,059
-3,731
-4% -$333K 0.06% 428
2023
Q2 		$8.5M Sell
99,790
-1,738
-2% -$147K 0.05% 483
2023
Q1 		$8.4M Sell
101,528
-795
-0.8% -$64.4K 0.06% 476
2022
Q4 		$8.05M Sell
102,323
-2,232
-2% -$179K 0.06% 483
2022
Q3 		$7.74M Sell
104,555
-3,129
-3% -$225K 0.06% 448
2022
Q2 		$7.02M Sell
107,684
-3,416
-3% -$202K 0.05% 545
2022
Q1 		$7.02M Sell
111,100
-1,588
-1% -$86.4K 0.04% 645
2021
Q4 		$5.98M Sell
112,688
-2,130
-2% -$130K 0.03% 740
2021
Q3 		$8.11M Sell
114,818
-3,331
-3% -$210K 0.04% 577
2021
Q2 		$7.87K Buy
118,149
+25,563
+28% +$1.81M 0.03% 653
2021
Q1 		$10.3K Buy
92,586
+411
+0.4% +$50.9K 0.04% 499
2020
Q4 		$10.9K Sell
92,175
-1,350
-1% -$145K 0.04% 400
2020
Q3 		$8.16M Sell
93,525
-1,274
-1% -$111K 0.04% 451
2020
Q2 		$8.49M Sell
94,799
-33,115
-26% -$3.34M 0.04% 414
2020
Q1 		$12.7M Sell
127,914
-1,182
-0.9% -$128K 0.07% 219
2019
Q4 		$14.8M Buy
129,096
+179
+0.1% +$21.7K 0.06% 251
2019
Q3 		$16.3M Sell
128,917
-2,870
-2% -$364K 0.07% 210
2019
Q2 		$15.9M Sell
131,787
-1,760
-1% -$173K 0.06% 208
2019
Q1 		$11.7M Sell
133,547
-5,078
-4% -$462K 0.04% 321
2018
Q4 		$13.9M Buy
138,625
+4
+0% +$420 0.06% 216
2018
Q3 		$15.9M Sell
138,621
-487
-0.4% -$50.4K 0.05% 225
2018
Q2 		$12.5M Buy
139,108
+104,675
+304% +$8.84M 0.04% 274
2018
Q1 		$2.52M Sell
34,433
-7,838
-19% -$538K 0.01% 922
2017
Q4 		$2.46M Buy
42,271
+743
+2% +$39.1K 0.01% 944
2017
Q3 		$1.86M Buy
41,528
+2,274
+6% +$94.5K 0.01% 1019
2017
Q2 		$1.55M Buy
39,254
+8,314
+27% +$341K 0.01% 1062
2017
Q1 		$1.25M Sell
30,940
-6,641
-18% -$259K ﹤0.01% 1101
2016
Q4 		$1.51M Sell
37,581
-495
-1% -$18.7K 0.01% 1033
2016
Q3 		$1.38M Buy
38,076
+16
+0% +$549 0.01% 1052
2016
Q2 		$1.1M Sell
38,060
-784
-2% -$23.7K ﹤0.01% 1124
2016
Q1 		$1.36M Buy
38,844
+1,759
+5% +$56.8K 0.01% 1303
2015
Q4 		$1.2M Buy
37,085
+373
+1% +$12.1K ﹤0.01% 1393
2015
Q3 		$1.19M Buy
36,712
+121
+0.3% +$4.55K 0.01% 1346
2015
Q2 		$1.51M Sell
36,591
-2,397
-6% -$101K 0.01% 1295
2015
Q1 		$1.75M Buy
38,988
+196
+0.5% +$8.19K 0.01% 1232
2014
Q4 		$1.45M Sell
38,792
-1,181
-3% -$43.3K 0.01% 1299
2014
Q3 		$1.4M Buy
39,973
+228
+0.6% +$8.14K 0.01% 1317
2014
Q2 		$1.4M Sell
39,745
-230
-0.6% -$7.68K 0.01% 1331
2014
Q1 		$1.3M Buy
39,975
+1,108
+3% +$42.3K 0.01% 1342
2013
Q4 		$1.64M Buy
38,867
+229
+0.6% +$9.42K 0.01% 1163
2013
Q3 		$1.54M Sell
38,638
-641
-2% -$26.9K 0.01% 1155
2013
Q2 		$1.62M Buy
+39,279
New +$1.59M 0.01% 1134

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's HAE Position: Q2 2024 in Review

American International Group sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 91,532 shares — an estimated $7.81M sold.

American International Group first reported a position in HAE in Q2 2013 and held it in 44 quarters. The position peaked at $16.3M in Q3 2019. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • American International Group reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 91,532 Haemonetics shares in Q2 2024, an estimated $7.81M.
  • American International Group first reported a position in Haemonetics in Q2 2013 and held it in 44 quarters.
  • American International Group's Haemonetics position peaked at $16.3M in Q3 2019.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.